News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pegasus Pharmaceuticals Inc./Heartview Signs Multi-Year Sales Agreement For China For Ground-Breaking HeartVue(TM) 6C System Technology



2/9/2006 3:12:27 PM

Pegasus/Heartview LLC (OTC: PGUZ) today announced that it has signed a sales agreement to market and distribute its HeartVue™ 6C System in China and southern Asia through the Pegasus PharmGroup and its marketing subsidiary, Pegasus Lifecare Inc.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES